English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Business Local Biz
CisgenX Awarded Smart Approved WaterMark Certification for Innovative Irrigation Solutions
Oct 03, 2024 14:47 HKT
Spa IZUMI launches YON-KA Phyto Sleep Ritual
Oct 03, 2024 12:00 HKT
Doubleview Provides Exploration Update at the Hat Polymetallic Mineral Deposit, 2024 Drilling Now Exceeds 7,500 m
Oct 01, 2024 21:09 HKT
OSK Property Welcomes PeopleUp Singapore with Its First Flagship Family Entertainment Concept in Atria Shopping Gallery
Sep 25, 2024 20:00 HKT
Ensign InfoSecurity Recognised as Honouree in NextGen Tech 30, ASEAN's First Public-Private Initiative to Recognise Growth Companies of the Region
Sep 24, 2024 09:00 HKT
Lack of quality data and disconnected tech stack impacting Singapore businesses amid rising costs and competition: HubSpot Research
Sep 23, 2024 14:00 HKT
Solar District Cooling Group Berhad Commences Trading on ACE Market with Strong Opening Price of RM0.500
Sep 19, 2024 14:30 HKT
AI Essentials For Small Businesses to Drive Growth and Save Time
Sep 17, 2024 17:20 HKT
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
Sep 13, 2024 17:50 HKT
Belt and Road Summit Opened Today
Sep 11, 2024 18:22 HKT
Legacy Secures Four Companies for US Listing
Sep 04, 2024 15:00 HKT
Singapore's construction industry set to outpace the country's GDP growth rate this year
Sep 04, 2024 10:00 HKT
GMG Provides Update on Modular Graphene Production Plant & Capital Expenditure
Sep 03, 2024 20:59 HKT
HKIoD Recommends Board Readiness Training for First-time Directors Before Appointment
Aug 28, 2024 14:25 HKT
香港董事学会建议首次担任董事前需接受专业培训
Aug 28, 2024 14:11 HKT
香港董事學會建議首次擔任董事前需接受專業培訓
Aug 28, 2024 13:38 HKT
Cisgenics Brings Next-Generation Irrigation Technology to Australia
Aug 28, 2024 13:03 HKT
Hektar REIT's Q2 Realised Net Income Up 42.8% Backed by Enlarged and Diversified Asset Portfolio
Aug 25, 2024 22:15 HKT
日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请
Aug 24, 2024 08:00 HKT
日本厚生勞動省批准了莫德納公司針對SARS-COV-2 JN.1變異株的COVID-19 mRNA疫苗的部分變更申請
Aug 24, 2024 08:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: